New data from the Australian Institute of Health and Welfare (AIHW) reveals a worrying trend: prostate cancer diagnoses are rising sharply, and younger men are increasingly affected.
According to the AIWH data, 29,000 new cases of prostate cancer are likely to be diagnosed in 2025, making up 30% of cancer diagnoses in men.
The data also points to a sharp rise in younger diagnoses, with cases among men in their 30s and 40s once considered rare now steadily increasing.
The story of Joel Brooker, diagnosed at the age of just 33 after a PSA test, underscores the value of vigilance - even among younger men.
PCFA CEO Anne Savage said the data is a strong reminder that early detection saves lives.
"Men, especially those in their 40s, do not need to wait for symptoms. Those with a family history should talk to their GP about PSA testing and stay informed about their risk," Ms Savage said.
"Our health system must be better equipped to manage the growing burden of diagnosis, treatment, and survivorship.
"Updated, evidence-based screening guidelines are urgently needed to balance benefit, risk, and access. And research, awareness, and Government investment must be ramped up now, or future projections suggest even greater pressure on service capacity and avoidable mortality.
"We stand by Australian men and their families: you do not have to wait for symptoms, and the conversation about prostate health matters-now more than ever," Ms Savage added.
Some key points from the report and related analysis:
* An estimated 29,000 new cases of prostate cancer will be diagnosed in 2025 - making up 30% of cancer diagnoses in men.
* Deaths from prostate cancer are projected at 4,000 this year, up from 2,700 in 2000.
* Remarkably, prostate cancer incidence is increasing in men in their 30s and 40s - cases once considered rare in younger age groups.
* Despite the increase in diagnoses, mortality rates have nearly halved since 1994, thanks in large part to earlier detection and better treatments.
- Read the story in The Australian.
- Download and share the latest prostate cancer statistics.
